Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Vitiligo is caused by the immune system attacking skin pigment cells.

Pertussis toxin may contribute to hair loss in alopecia areata.

The PML protein helps prevent skin cancer in mice.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Immortalized human dermal papilla cells were created that grow better and can still help form hair.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Blocking certain proteins on immune cells may help treat alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Antibodies help identify glycoproteins in normal skin and tumor cells.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Vesicles from irradiated mouse cheek skin help cells survive radiation.

PrEP implants are promising for HIV prevention if the number of implants needed is minimized.

Vitiligo and alopecia areata may have similar causes despite their differences.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Type B material, ground for 8 hours, is the most suitable and compatible for use as a soft tissue filler.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.